+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Pediatric Vaccine Market 2019-2023 - Product Image

Global Pediatric Vaccine Market 2019-2023

  • ID: 4756161
  • Report
  • Region: Global
  • 128 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • CSL Limited
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi
  • MORE
The prevalence of infectious diseases is high in the pediatric population, as the immune system of children is not fully developed. Therefore, infectious diseases are a leading cause of mortality in this population segment. Factors such as rising population as well as environmental and a few genetic factors are contributing to the rapidly growing incidences of infectious diseases. For instance, increased exposure to environmental factors such as ultraviolet radiation is responsible for the suppression of cell-based immunity in children, which makes them susceptible to numerous infectious diseases. Likewise, the rapid increase in birth rates is also a contributing factor to the rise in the number of infectious diseases. The increase in fertility rates is subsequently increasing the risk of maternally acquired infections such as HIV infection. All these factors are contributing to the increase in the prevalence of infectious diseases, which is further driving the market growth. The analysts have predicted that the pediatric vaccine market will register a CAGR of over 7% by 2023.

Market Overview

Strong late-stage pipeline and new drug approvals

The market contains a significant number of monotherapy- and combination therapy-based vaccines that are currently under the late stages of development and are expected to get approved during the forecast period. These vaccines possess a strong therapeutic potential for the prevention of a large number of infectious diseases and allergies in children. The therapeutic potential of these vaccines can be demonstrated by the results of clinical trials.

Hurdles to optimal use of vaccines

Hurdles such as supply constraints, inadequate vaccine coverage, and lack of knowledge regarding the importance of immunization are restricting the optimal use of vaccines in both developing as well as developed countries. However, the lack of vaccination coverage is responsible for millions of deaths among the pediatric population.

For the detailed list of factors that will drive and challenge the growth of the pediatric vaccine market during the 2019-2023, view this report.

Competitive Landscape

The pediatric vaccine market appears to be moderately concentrated and with the presence of limited vendors. The increasing prevalence of infectious diseases in pediatric population will drive the market growth This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • CSL Limited
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Conjugate vaccines and others - Market size and forecast 2018-2023
  • Live-attenuated vaccines - Market size and forecast 2018-2023
  • Toxoid vaccines - Market size and forecast 2018-2023
  • Inactivated vaccines - Market size and forecast 2018-2023
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TYPE
  • Monovalent vaccines
  • Multivalent vaccines
PART 10: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • CSL Limited
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global vaccine market
Exhibit 02: Segments of global vaccine market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Pediatric vaccines in the pipeline
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Conjugate vaccines and others - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Conjugate vaccines and others - Year-over-year growth 2019-2023 (%)
Exhibit 22: Sales of leading conjugate vaccines 2015-2017 ($ millions)
Exhibit 23: Live-attenuated vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Live-attenuated vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 25: Sales of leading live-attenuated vaccines 2015-2017 ($ millions)
Exhibit 26: Toxoid vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Toxoid vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 28: Inactivated vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Inactivated vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 30: Market opportunity by product
Exhibit 31: Customer landscape
Exhibit 32: Market share by geography 2018-2023 (%)
Exhibit 33: Geographic comparison
Exhibit 34: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: North America - Year-over-year growth 2019-2023 (%)
Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 38: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 40: Incidence rates for malaria 2017 (reported by the World Bank)
Exhibit 41: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 42: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 43: Key leading countries
Exhibit 44: Market opportunity
Exhibit 45: Immunization programs for children
Exhibit 46: Recently approved vaccines by the FDA
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Vendor landscape
Exhibit 49: Landscape disruption
Exhibit 50: Vendors covered
Exhibit 51: Vendor classification
Exhibit 52: Market positioning of vendors
Exhibit 53: CSL Limited - Vendor overview
Exhibit 54: CSL Limited - Business segments
Exhibit 55: CSL Limited - Organizational developments
Exhibit 56: CSL Limited - Geographic focus
Exhibit 57: CSL Limited - Segment focus
Exhibit 58: CSL Limited - Key offerings
Exhibit 59: GlaxoSmithKline plc - Vendor overview
Exhibit 60: GlaxoSmithKline plc - Business segments
Exhibit 61: GlaxoSmithKline plc - Organizational developments
Exhibit 62: GlaxoSmithKline plc - Geographic focus
Exhibit 63: GlaxoSmithKline plc - Segment focus
Exhibit 64: GlaxoSmithKline plc - Key offerings
Exhibit 65: Merck & Co., Inc. - Vendor overview
Exhibit 66: Merck & Co., Inc. - Business segments
Exhibit 67: Merck & Co., Inc. - Organizational developments
Exhibit 68: Merck & Co., Inc. - Geographic focus
Exhibit 69: Merck & Co., Inc. - Segment focus
Exhibit 70: Merck & Co., Inc. - Key offerings
Exhibit 71: Pfizer Inc. - Vendor overview
Exhibit 72: Pfizer Inc. - Business segments
Exhibit 73: Pfizer Inc. - Organizational developments
Exhibit 74: Pfizer Inc. - Geographic focus
Exhibit 75: Pfizer Inc. - Segment focus
Exhibit 76: Pfizer Inc. - Key offerings
Exhibit 77: Sanofi - Vendor overview
Exhibit 78: Sanofi - Business segments
Exhibit 79: Sanofi - Organizational developments
Exhibit 80: Sanofi - Geographic focus
Exhibit 81: Sanofi - Segment focus
Exhibit 82: Sanofi - Key offerings
Exhibit 83: Validation techniques employed for market sizing
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • CSL Limited
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi
  • MORE
Global Pediatric Vaccine Market 2019-2023

The analyst recognizes the following companies as the key players in the global pediatric vaccine market: CSL Limited, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising awareness of immunization in low- and- middle- income countries.”

According to the report, one of the major drivers for this market is the strong late- stage pipeline and new drug approvals.

Further, the report states that one of the major factors hindering the growth of this market is challenges associated with development, storage, and handling of vaccines.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • CSL Limited
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4756161
Adroll
adroll